Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis

被引:16
作者
Katzman, Joanna G. [1 ,2 ,3 ]
Greenberg, Nina H. [4 ]
Takeda, Mikiko Y. [5 ]
Balasch, Monica Moya [1 ]
机构
[1] Univ New Mexico, Dept Neurosurg, Sch Med, MSC 10-5615, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Coll Nursing, MSC 10-5615, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Dept Pharm Practice & Adm Serv, Coll Pharm, Albuquerque, NM 87131 USA
关键词
characteristics; harm reduction; naloxone; opioid; overdose; INJECTION-DRUG USERS; HEROIN OVERDOSE; NALOXONE;
D O I
10.1097/ADM.0000000000000461
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: The primary outcome of this study is to identify characteristics of study participants in a large opioid treatment program (OTP) for opioid use disorder (OUD) who used take-home naloxone to perform 1 or more opioid overdose (OD) reversal(s) in the community. Methods: This 6-month prospective cohort study provided take-home naloxone and opioid OD education for 287 study participants with OUD. Characteristics associated with use of the take-home naloxone were determined from among 16 variables using multivariable logistic regression. Results: The study participants who had greater odds of using the take-home naloxone to perform OD reversals, compared to those who did not use the take-home naloxone, (a) received emergency room care themselves for OD (OR = 4.89, 95% CI 1.54-15.52, P = 0.007), (b) previously witnessed someone else OD (OR = 5.67, 95% CI 1.24-25.87, P = 0.025), (c) tested positive for 2 or more illicit substances at their 6-month urine analysis (OR = 5.26, 95% CI 1.58-17.54, P = 0.007) or were missing their 6-month urine analysis (OR = 3.46, 95% CI 1.42-8.43, P = 0.006). In addition, they had greater odds of being (d) less than 30 years old (OR = 2.80, 95% CI 1.02-7.66, P = 0.045), and (e) Hispanic (OR = 3.98, 95% CI 1.41-11.21, P = 0.009). Conclusions: This study prospectively identified several characteristics of patients enrolled in an OTP with increased odds of using take-home naloxone in their social networks. Future harm reduction efforts may benefit by using targeted characteristics to identify those most likely to use naloxone in their communities.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [21] Treatment Updates for Pain Management and Opioid Use Disorder
    Locke, Thomas
    Salisbury-Afshar, Elizabeth
    Coyle, David Tyler
    MEDICAL CLINICS OF NORTH AMERICA, 2023, 107 (06) : 1035 - 1046
  • [22] Naloxone prescription fills and use by patients treated for opioid use disorder by telehealth
    Weiner, Scott G.
    Miller, Emily N.
    Burke, Barbara
    Clear, Brian
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2024, 11
  • [23] Community Pharmacists' Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder
    Lehr, Victoria Tutag
    Nolan, Claire
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (04) : E224 - E231
  • [24] Opioid overdose response training in pharmacy education: An analysis of students' perception of naloxone use for opioid overdose prevention
    Bachyrycz, Amy
    Takeda, Mikiko Y.
    Wittstrom, Kristina
    Bleske, Barry
    CURRENTS IN PHARMACY TEACHING AND LEARNING, 2019, 11 (02) : 166 - 171
  • [25] Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose
    Jones, Christopher M.
    Shoff, Carla
    Blanco, Carlos
    Losby, Jan L.
    Ling, Shari M.
    Compton, Wilson M.
    JAMA INTERNAL MEDICINE, 2024, 184 (08) : 954 - 962
  • [26] Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study
    Tipping, Andrew D.
    Nowels, Molly
    Moore, Clara
    Samples, Hillary
    Crystal, Stephen
    Olfson, Mark
    Williams, Arthur Robinson
    -Woodruff, Jodi Heaps
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 157
  • [27] Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population
    Bascou, Nicholas Alexander
    Haslund-Gourley, Benjamin
    Amber-Monta, Katrina
    Samson, Kyle
    Goss, Nathaniel
    Meredith, Dakota
    Friedman, Andrew
    Needleman, Andrew
    Kumar, Vishnu K.
    Fischer, Bradford D.
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [28] Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis
    Fischer, Leah S.
    Asher, Alice
    Stein, Renee
    Becasen, Jeffrey
    Doreson, Amanda
    Mermin, Jonathan
    Meltzer, Martin I.
    Edlin, Brian R.
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [29] Impacts of a Medicaid "lock-in" program on opioid use disorder treatment and services and naloxone dispensing
    Naumann, Rebecca B.
    Austin, Anna E.
    Wang, Lily
    Roberts, Andrew W.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 233
  • [30] Overdose Experiences Among a Sample of Women in Jail with Opioid Use Disorder
    Dickson, Megan F.
    Annett, Jaxin
    Walker, Meghan
    Leukefeld, Carl
    Webster, J. Matthew
    Levi, Mary M.
    Tillson, Martha
    Staton, Michele
    SUBSTANCE USE & MISUSE, 2024, 59 (13) : 1911 - 1920